Patients with an aggressive form of blood cancer, acute myeloid leukemia, previously had little chance of recovery when the disease returned. Researchers in Dresden have changed this. With a new combination of therapies, three times as many patients now achieve the decisive step towards a cure. | more
Today, nine out of ten children with leukemia survive their illness. However, many suffer from the consequences of chemotherapy for the rest of their lives. Researchers at the NCT/UCC Dresden are working on gentler treatments. Using CRISPR technology and precision medicine, they are looking for molecular weak points in cancer cells. Their goal: in ten years, only half as much chemotherapy. | more
